This inventor holds 1 USPTO granted patent. Top assignee: Baxter International Inc.. Active years: 2004.
Company Filing History:
Years Active: 2004
Title: Innovations of John Womelsdorf in Medical Device Technology.
Introduction
John Womelsdorf is an accomplished inventor based in Caldwell, NJ (US). He has made significant contributions to the field of medical devices, particularly in the delivery of biochemically reactive fluids. His innovative approach has led to the development of a unique device that enhances the efficiency and effectiveness of fluid delivery in medical applications.
Latest Patents
Womelsdorf holds a patent for a "Mechanical breakup unit for biochemically reactive fluid delivery device." This invention provides a medical device designed to deliver volumetric quantities of two biochemically reactive fluids. The device features separate mechanical breakup units (MBUs) that atomize the fluids, ensuring precise delivery during medical procedures. The design includes two feed conduits that direct fluids into spin chambers, creating a spray of two fluids with different viscosities, such as fibrinogen and thrombin. This innovative mechanism allows for the thrombin spray cone to encompass the fibrinogen spray cone, optimizing the reaction process and minimizing the risk of unreacted fibrinogen deposition.
Career Highlights
Womelsdorf is currently employed at Baxter International Inc., a leading company in the healthcare sector. His work focuses on advancing medical technologies that improve patient outcomes. With a patent portfolio that includes one significant invention, he continues to push the boundaries of medical device innovation.
Collaborations
Throughout his career, Womelsdorf has collaborated with notable colleagues, including David W. Pennington and Atif M. Yardimci. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of medical technology.
Conclusion
John Womelsdorf's contributions to medical device technology exemplify the impact of innovation in healthcare. His patented invention demonstrates a commitment to improving medical procedures through advanced fluid delivery systems. As he continues to work at Baxter International Inc., his efforts will undoubtedly lead to further advancements in the field.